Varda Space Industries
develops medicines in microgravity using dedicated re-entry capsules to return product to Earth, and signed a collaboration agreement with a major US pharmaceutical firm to advance microgravity-enabled treatments for a rare pulmonary disease.
- Country
- United States
Commercial
Coverage
| CN | EU | US | |
|---|---|---|---|
| upstream-bioreactors | ✓ | ✓ | ✓ |
Regulatorsfdafaa
Technologies
| Name | Cluster | Risk | |
|---|---|---|---|
| Space bioeconomy | upstream-bioreactors | Medium | → |
Compiled by BIOECON via the bioecon-brief pipeline.
Compliance
Bioecon is an information intermediary; it is not a regulator, a certification body, or a legal advisor. When working with public-sector customers (procurement under 44-FZ / 223-FZ), Bioecon acts solely as an independent analytical platform, with no remuneration from suppliers.